Abstract
Synthesis of (1-acyloxyethylidene)-1,1-bisphosphonic acids, where the acyl group is decanoyl (1a ), lauroyl (1b ), palmitoyl (1c ), stearoyl (1d ) or oleoyl (1e ) have been described. Preparation of (1-oleoyloxyethylidene)-1,1-bisphosphonic acid tetramethyl ester (2 ) and its P ,P ′-dimethyl ester (disodium salt 3 and acid form 4 ) in multigram scale has also been reported. Solubility of 1e in organic solvents and water was tested.
Key words
bisphosphonate - etidronate - fatty acids - synthesis - prodrug
References
1a
Fleisch H.
Bisphosphonates in Bone Disease: From the Laboratory to the Patient
The Parthenon Publishing Group Inc.;
New York:
1995.
1b
Papapoulos SE.
Landman JO.
Bijvoet OLM.
Löwik CWGM.
Valkema R.
Pauwels EKJ.
Vermeij P.
Bone
1992,
13:
S41
1c
Yates AJ.
Rodan GA.
DDT
1998,
3:
69
1d
Socrates E.
Papapoulos MD.
Am. J. Med.
1993,
95:
48S
1e
Giannini S.
D’Angelo AL.
Sartori LG.
Passeri G.
Garbonare LD.
Crebaldi C.
Obst. Gynecol.
1996,
88:
431
2a
Szajnman SH.
Montalvetti A.
Wang Y.
Docampo R.
Rodriguez JB.
Bioorg. Med. Chem. Lett.
2003,
13:
3231
2b
Szajnman SH.
Bailey BN.
Docampo R.
Rodriguez JB.
Bioorg. Med. Chem. Lett.
2001,
11:
789
2c
Martin MB.
Sanders JM.
Kendrick H.
Luca-Fradley K.
Lewis JC.
Grimley JS.
Van Brussel EM.
Olsen JR.
Meints GA.
Burzynska A.
Kafarski P.
Croft SL.
Oldfield E.
J. Med. Chem.
2002,
45:
2904
2d
Garzoni LR.
Caldera A.
Nazareth L.
Meirelles M.
Castro SL.
Docampo R.
Meints GA.
Oldfield E.
Urbina JA.
Int. J. Antimicrob. Agents
2004,
23:
273
2e
Garzoni LR.
Waghabi MC.
Baptista MM.
Castro SL.
Nazareth L.
Meirelles M.
Britto CC.
Docampo R.
Oldfield E.
Urbina JA.
Int. J. Antimicrob. Agents
2004,
23:
286
3
Ylitalo R.
Gen. Pharmacol.
2002,
35:
287
4a
Vepsäläinen JJ.
Curr. Med. Chem.
2002,
9:
1201
4b
Lin JH.
Bone
1996,
18:
75
4c
Recker RR.
Saville PD.
Toxicol. Appl. Pharmacol.
1973,
24:
580
5a
Turhanen PA.
Niemi R.
Peräkylä M.
Järvinen T.
Vepsäläinen JJ.
Org. Biomol. Chem.
2003,
1:
3223
5b
Ahlmark M.
Vepsäläinen J.
Taipale H.
Niemi R.
Järvinen T.
J. Med. Chem.
1999,
42:
1473
5c
Niemi R.
Vepsäläinen J.
Taipale H.
Järvinen T.
J. Med. Chem.
1999,
42:
5053
5d
Niemi R.
Turhanen P.
Vepsäläinen J.
Taipale H.
Järvinen T.
Eur. J. Pharm. Sci.
2000,
11:
173
5e
Turhanen PA.
Ahlgren MJ.
Järvinen T.
Vepsäläinen JJ.
Synthesis
2001,
633
5f
Turhanen PA.
Vepsäläinen JJ.
Synthesis
2004,
992
6
Turhanen PA.
Vepsäläinen JJ.
Synthesis
2005,
2119
7 Turhanen, P. A.; Vepsäläinen, J. J., Synthesis, submitted.
8a
Pudovik AN.
Konovalova IV.
J. Gen. Chem. USSR
1963,
33:
91
8b
Pudovik AN.
Gazizov TKh.
J. Gen. Chem. USSR
1968,
38:
139
8c
Prentice JB.
Quimby OT.
Grabenstetter RJ.
Nicholson DA.
J. Am. Chem. Soc.
1972,
94:
6119
8d
Chopard PA.
Helv. Chim. Acta
1967,
50:
1021
8e
Ruel R.
Bouvier J.-P.
Young RN.
J. Org. Chem.
1995,
60:
5209
8f
Guenin E.
Degache E.
Liquier J.
Lecouvey M.
Eur. J. Org. Chem.
2004,
2983
9a
Nicholson DA.
Vaughn H.
J. Org. Chem.
1971,
36:
3843
9b
Turhanen PA.
Ahlgren MJ.
Järvinen T.
Vepsäläinen JJ.
Phosphorus, Sulfur Silicon Relat. Elem.
2001,
170:
115
10a
Mc Kenna CE.
Shen P.
J. Org. Chem.
1981,
46:
4573
10b
Vaghefi MM.
Bernacki RJ.
Hennen WJ.
Robins RK.
J. Med. Chem.
1987,
30:
1391
10c
Nguyen LM.
Niesor E.
Bentzen CL.
J. Med. Chem.
1987,
30:
1426
10d
Ebetino FH.
Degenhardt CR.
Jamieson LA.
Burdsall DC.
Heterocycles
1990,
30:
855
10e
Nugent RA.
Murphy M.
Schlachter ST.
Dunn CJ.
Smith RJ.
Staite ND.
Galinet LA.
Shields SK.
Aspar DG.
Richard KA.
Rohloff NA.
J. Med. Chem.
1993,
36:
134
11
Van Gelder JM.
Breuer E.
Ornoy A.
Schlossman A.
Patlas N.
Golomb G.
Bone
1995,
16:
511